test

Our Latest News In:

health

health

Gilead profit beats Street expectations on COVID and HIV sal
Eli Lilly raises 2023 profit forecast
Merck fourth quarter tops expectations on strong COVID pill
Roche flags 2023 earnings decline on slump in COVID products
Analysis-GSK gives few clues on plans to replenish medicine
Humana quarterly profit beats estimates
GSK reports Q4 profit, sales beat Wall Street estimates
Amgen revenue falls slightly as Lilly COVID deal contributes
Pfizer forecasts 2023 sales of COVID products below estimate
AbbVie's Humira gets a U.S. rival, but costs could stay high
Warren tells FTC she is "particularly concerned" about Amgen
Staffing woes set to weigh on hospital operator's profits
Roche launches new test to detect fast spreading Omicron sub
China's luxury shoppers free to travel, but many buy locally
Abbott beats profit estimate on diagnostics, diabetes device
Eli Lilly to invest $450 million more to expand diabetes dru
DJIA SNAPSHOT
* Market data is delayed
MARKET INFORMATION
 LASTCHG
  DJIA 34,036.00 +0  0 %
  NASDAQ 469.50 +0  0 %
  S&P 500 0.00 +0  0 %
  OIL 2,901.00 +0  0 %


Investor Alley / Sponsored Content
WE PROFILE LOTS OF AMAZING STOCKS
Our job and our passion is sharing awesome companies that can be overlooked by wallstreet. We love finding the diamonds in the rough that could turn into the next big mover in the markets and we enjoy sharing ideas in our Investor Alley with picks like these:

1D 3M 1Y

This Is A Paid Advertisement. View Full Disclaimer

1D 3M 1Y

This Is A Paid Advertisement. View Full Disclaimer